William H. Collier
Director/Board Member chez Genevant Sciences Corp.
Fortune : - $ au 31/03/2024
Profil
William H.
Collier is currently a Director at Genevant Sciences Corp.
He was previously the President, Chief Executive Officer & Director at Arbutus Biopharma Corp.
from 2019 to 2023, President & Chief Executive Officer at Arbutus Biopharma, Inc., Director at International Partnership for Microbicides from 2018 to 2021, Area Director at Glaxowellcom, Director at Aids United from 2011 to 2018, and President & GM-North America Region at ViiV Healthcare Ltd.
Mr. Collier obtained an undergraduate degree from the University of Manchester Institute of Science & Technology.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/03/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de William H. Collier
| Sociétés | Poste | Début |
|---|---|---|
Genevant Sciences Corp.
 Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The private company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Director/Board Member | - |
Anciens postes connus de William H. Collier
| Sociétés | Poste | Fin |
|---|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Chief Executive Officer | 31/12/2023 |
Arbutus Biopharma, Inc.
 Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Chief Executive Officer | 31/12/2023 |
International Partnership for Microbicides
 International Partnership for Microbicides BiotechnologyHealth Technology The International Partnership for Microbicides develops products for the prevention of human immunodeficiency virus. The private company is based in Silver Spring, MD. | Director/Board Member | 01/01/2021 |
| Aids United | Director/Board Member | 01/01/2018 |
| Glaxowellcom | Corporate Officer/Principal | - |
Formation de William H. Collier
| University of Manchester Institute of Science & Technology | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Health Technology |
| Entreprise privées | 6 |
|---|---|
International Partnership for Microbicides
International Partnership for Microbicides BiotechnologyHealth Technology The International Partnership for Microbicides develops products for the prevention of human immunodeficiency virus. The private company is based in Silver Spring, MD. | Health Technology |
Arbutus Biopharma, Inc.
Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Health Technology |
| Glaxowellcom | |
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Health Technology |
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The private company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Health Technology |
| Aids United |
